Protocol Modifications for CT Perfusion (CTp) Examinations of Abdomen-pelvic Tumors: Impact on Radiation Dose and Data Processing Time

Overview

Journal Eur Radiol

Specialty Radiology

Date 2011 Jan 20

PMID 21246200

Citations 14

Authors

Avinash R Kambadakone

Ashish Sharma

Onofrio A Catalano

Peter F Hahn

Dushyant V Sahani

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the effect of CT perfusion (CTp) protocol modifications on quantitative perfusion parameters, radiation dose and data processing time.

Materials & Methods: CTp datasets of 30 patients (21M:9F) with rectal (n = 24) or retroperitoneal (n = 6) tumours were studied. Standard CTp protocol included 50 sec cine-phase (0.5 sec/rotation) and delayed-phase after 70 ml contrast bolus at 5-7 ml/sec. CTp-data was sub-sampled to generate modified datasets (n = 105) with cine-phase(n = 15) alone, varying cine-phase duration (20-40 sec, n = 45) and varying temporal sampling-interval (1-3 sec, n = 45). The estimated CTp parameters (BF,BV,MTT&PS) and radiation dose of standard CTp served as reference for comparison.

Results: CTp with 50 sec cine-phase showed moderate to high correlation with standard CTp for BF&MTT (r = 0.96&0.85) and low correlation for BV (0.75, p = 0.04). Limiting cine-phase duration to 30 sec demonstrated comparable results for BF&MTT, while considerable variation in CTp values existed at 20 sec. There was moderate-to-high correlation of CTp parameters with sampling interval of 1&2 sec (r = 0.83-0.97, p > 0.05), while at 3 sec only BF showed high correlation (r = 0.96, p = 0.05). Increasing sampling interval (47-60%) and reducing cine-phase duration substantially reduced dose(30.8-65%) which paralleled reduced data processing time (3-10 min).

Conclusion: Limiting CTp cine-phase to 30 sec results in comparable BF&MTT values and increasing cine-phase sampling interval to 2 sec provides good correlation for all CTp parameters with substantial dose reduction and improved computational efficiency.

Citing Articles

Quantitative evaluation of pancreatic neuroendocrine tumors utilizing dual-source CT perfusion imaging.

Liu G, Gao Y, Li X, Huan Y, Chen J, Deng Y BMC Med Imaging. 2024; 24(1):325.

PMID: 39623298 PMC: 11613872. DOI: 10.1186/s12880-024-01511-1.

Effect of scan duration on CT perfusion values in metastases from renal cell carcinoma.

Ng C, Chandler A, Chen Y, Wei W, Tannir N, Hobbs B Res Diagn Interv Imaging. 2024; 6:100028.

PMID: 39077545 PMC: 11265368. DOI: 10.1016/j.redii.2023.100028.

Intra- and interobserver reproducibility of pancreatic perfusion by computed tomography.

Garcia T, Engelholm J, Vouche M, Hirakata V, Leitao C Sci Rep. 2019; 9(1):6043.

PMID: 30988325 PMC: 6465241. DOI: 10.1038/s41598-019-42519-w.

Variability and Reproducibility of 3-generation dual-source dynamic volume perfusion CT Parameters in Comparison to MR-perfusion Parameters in Rectal Cancer.

Sudarski S, Henzler T, Floss T, Gaa T, Meyer M, Haubenreisser H Sci Rep. 2018; 8(1):6868.

PMID: 29720622 PMC: 5932032. DOI: 10.1038/s41598-018-25307-w.

Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease.

Topcuoglu O, Karcaaltincaba M, Akata D, Ozmen M Diagn Interv Radiol. 2016; 22(6):495-500.

PMID: 27759566 PMC: 5098942. DOI: 10.5152/dir.2016.16612.

References

Miles K . Perfusion imaging with computed tomography: brain and beyond. Eur Radiol. 2008; 16 Suppl 7:M37-43. DOI: 10.1007/s10406-006-0194-1. View

Sahani D, Holalkere N, Mueller P, Zhu A . Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology. 2007; 243(3):736-43. DOI: 10.1148/radiol.2433052020. View

DAssignies G, Couvelard A, Bahrami S, Vullierme M, Hammel P, Hentic O . Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2008; 250(2):407-16. DOI: 10.1148/radiol.2501080291. View

Kamena A, Streitparth F, Grieser C, Lehmkuhl L, Jamil B, Wojtal K . Dynamic perfusion CT: optimizing the temporal resolution for the calculation of perfusion CT parameters in stroke patients. Eur J Radiol. 2007; 64(1):111-8. DOI: 10.1016/j.ejrad.2007.02.025. View

Goh V, Padhani A . Imaging tumor angiogenesis: functional assessment using MDCT or MRI?. Abdom Imaging. 2005; 31(2):194-9. DOI: 10.1007/s00261-005-0387-4. View

Miles K, Charnsangavej C, Lee F, Fishman E, Horton K, Lee T . Application of CT in the investigation of angiogenesis in oncology. Acad Radiol. 2000; 7(10):840-50. DOI: 10.1016/s1076-6332(00)80632-7. View

Gandhi D, Chepeha D, Miller T, Carlos R, Bradford C, Karamchandani R . Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol. 2006; 27(1):101-6. PMC: 7976069. View

Axel L . Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol. 1983; 18(1):94-9. DOI: 10.1097/00004424-198301000-00018. View

Zhu A, Holalkere N, Muzikansky A, Horgan K, Sahani D . Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist. 2008; 13(2):120-5. DOI: 10.1634/theoncologist.2007-0174. View

10.

Miles K . Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol. 1999; 30(3):198-205. DOI: 10.1016/s0720-048x(99)00012-1. View

11.

Goh V, Liaw J, Bartram C, Halligan S . Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: implications for helical volumetric perfusion CT techniques. AJR Am J Roentgenol. 2008; 191(6):W288-92. DOI: 10.2214/AJR.07.3985. View

12.

Wiesmann M, Berg S, Bohner G, Klingebiel R, Schopf V, Stoeckelhuber B . Dose reduction in dynamic perfusion CT of the brain: effects of the scan frequency on measurements of cerebral blood flow, cerebral blood volume, and mean transit time. Eur Radiol. 2008; 18(12):2967-74. DOI: 10.1007/s00330-008-1083-x. View

13.

Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Alberzoni C . Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol. 2008; 15(7):919-27. DOI: 10.1016/j.acra.2008.02.005. View

14.

Mori S, Obata T, Nakajima N, Ichihara N, Endo M . Volumetric perfusion CT using prototype 256-detector row CT scanner: preliminary study with healthy porcine model. AJNR Am J Neuroradiol. 2005; 26(10):2536-41. PMC: 7976175. View

15.

Li Y, Yang Z, Chen T, Deng Y, Yu J, Li Z . Whole tumour perfusion of peripheral lung carcinoma: evaluation with first-pass CT perfusion imaging at 64-detector row CT. Clin Radiol. 2008; 63(6):629-35. DOI: 10.1016/j.crad.2007.12.012. View

16.

Hermans R, Meijerink M, Van den Bogaert W, Rijnders A, Weltens C, Lambin P . Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 57(5):1351-6. DOI: 10.1016/s0360-3016(03)00764-8. View

17.

Sahani D, Kalva S, Hamberg L, Hahn P, Willett C, Saini S . Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005; 234(3):785-92. DOI: 10.1148/radiol.2343040286. View

18.

Meijerink M, van Cruijsen H, Hoekman K, Kater M, van Schaik C, van Waesberghe J . The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol. 2006; 17(7):1700-13. DOI: 10.1007/s00330-006-0425-9. View

19.

Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji S . Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?. AJNR Am J Neuroradiol. 2007; 28(2):328-34. PMC: 7977386. View

20.

Dugdale P, Miles K, Bunce I, Kelley B, Leggett D . CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr. 1999; 23(4):540-7. DOI: 10.1097/00004728-199907000-00010. View